Jump to content

Draft:MycoMeditations

From Wikipedia, the free encyclopedia
  • Comment: the draft now appears to have an over reliance on primary sources. The majority of an article's content should be based off reliable secondary sources. Justiyaya 22:33, 17 May 2024 (UTC)


MycoMeditations
Company typePrivate
IndustryPsychedelic Therapy
Founded2014
Key people
Justin Townsend (Chief Executive Officer)
Websitemycomeditations.com

MycoMeditations is a psychedelic retreat company located in Jamaica.

It asserts itself as one of the longest-running therapeutic psychedelic retreats in the world, having been in operation since 2014.[1] It is one of numerous retreat companies on the island utilizing psilocybin mushrooms, which are legal for personal use in Jamaica.[2]

The company provides private psilocybin therapy sessions, and integration through individual and group psychotherapy.[3] MycoMeditations has gained a reputation for providing psilocybin doses as high as 15 grams[4], as opposed to lower doses used in clinical studies[5]. People reportedly attend MycoMeditations to treat mental health conditions, though there are no published clinical studies on their outcomes.[6] The company conducts safety screenings prior to people attending[7], as psychedelic therapy can be unsafe for some individuals.[8]

Conde Nast Traveler included MycoMeditations in it's overview of top psychedelic travel experiences in 2024[9], and numerous journalists have attended and reported about their experiences at the retreat, such as Decca Aitkenhead in the Sunday Times[10], Michael Verdon in Robb Report[11], and Charlet Duboc in VICE[12].

References

[edit]
  1. ^ "Medical breakthrough for mental disorder sufferers". jamaica-gleaner.com. 2024-02-28. Retrieved 2024-08-23.
  2. ^ Chappell, Kate (November 24, 2022). "Psychedelic mushrooms expand Jamaica tourism beyond sunshine and reggae". Reuters.
  3. ^ "At a Magic Mushroom Retreat, a Comedian Reluctantly Embraces Her "Healing Journey"". AFAR Media. 2023-12-12. Retrieved 2024-08-23.
  4. ^ "Medical breakthrough for mental disorder sufferers". jamaica-gleaner.com. 2024-02-28. Retrieved 2024-08-29.
  5. ^ Garcia-Romeu, Albert; Barrett, Frederick S.; Carbonaro, Theresa M.; Johnson, Matthew W.; Griffiths, Roland R. (April 2021). "Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches". Journal of Psychopharmacology (Oxford, England). 35 (4): 353. doi:10.1177/0269881121991822. PMID 33611977.
  6. ^ Hlavinka, Elizabeth (2023-10-01). "Psychedelic retreats are becoming more popular as patients wait for FDA approval. But do they work?". Salon. Retrieved 2024-08-23.
  7. ^ "Head to Jamaica for Microdosing Magic Mushroom Trips". Paradise. Retrieved 2024-08-29.
  8. ^ Smith, Dana G. (2023-02-10). "Psychedelics Are a Promising Therapy, but They Can Be Dangerous for Some". The New York Times. ISSN 0362-4331. Retrieved 2024-08-23.
  9. ^ Trimble, Michaela (2024-04-17). "Psychedelic Travel Experiences Are More Popular Than Ever". Condé Nast Traveler. Retrieved 2024-09-03.
  10. ^ Aitkenhead, Decca (2024-09-03). "How a Jamaican psychedelic mushroom retreat helped me process my grief". www.thetimes.com. Retrieved 2024-09-03.
  11. ^ Verdon, Michael (2022-08-07). "I Tripped on Mushrooms (Legally) at a Therapy Retreat in Jamaica. It May Have Changed My Life". Robb Report. Retrieved 2024-09-03.
  12. ^ VICE News (2022-01-11). The Battle Over Psychedelic Therapy’s Future. Retrieved 2024-09-03 – via YouTube.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:MycoMeditations&oldid=1243855281"